31 October 2023 - The EMA’s CHMP has recommended authorising an adapted Nuvaxovid vaccine targeting the Omicron XBB.1.5 subvariant of ...
28 October 2023 - The COVID-19 treatments millions of Americans have taken for free from the Federal Government will enter ...
20 October 2023 - A statement from Australia's Chief Medical Officer, Professor Paul Kelly, on the end of the COVID-19 emergency ...
18 October 2023 - Health insurance plans will likely pay much less than the nearly $1,400 list price for Paxlovid, ...
16 October 2023 - European Union regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the ...
3 October 2023 - Today, the US FDA amended the emergency use authorisation of the Novavax COVID-19 vaccine, adjuvanted for use ...
28 September 2023 - Spikevax XBB.1.5 approved for persons aged 18 and over ...
28 September 2023 - The updated vaccine is expected to be available in Canada in the coming weeks. ...
20 September 2023 - It has been just over a week since the US FDA and the US Centers for ...
20 September 2023 - PHARMAC is widening access to COVID-19 anti-virals to people who are vulnerable to severe infection from ...
15 September 2023 - The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and ...
18 September 2023 - The Ministry of Health has released a summary of the New Zealand Government’s procurement process for ...
14 September 2023 - EMA’s human medicines committee (CHMP) has recommended authorising an adapted Spikevax vaccine targeting the Omicron XBB.1.5 ...
12 September 2023 - Health Canada has authorised the use of the Moderna Spikevax COVID-19 vaccine targeting the Omicron XBB.1.5 ...
11 September 2023 - Today, the US FDA took action approving and authorising for emergency use updated COVID-19 vaccines formulated to ...